const e=JSON.parse(`{"key":"v-54e3633a","path":"/blog/pharma/phases.html","title":"Clinical trials basics","lang":"en-US","frontmatter":{"title":"Clinical trials basics","icon":"post","order":2,"category":["Clinical Trials"],"tag":["Tool"],"summary":"Four phases in clinical trials Phase 1: Purpose: safety and dosage; refine phase 2 design; 20-100 healthy volunteers or patients with disease condition; Approximately 70% of drugs ","head":[["meta",{"property":"og:url","content":"https://vuepress-theme-hope-v2-demo.mrhope.site/blog/pharma/phases.html"}],["meta",{"property":"og:site_name","content":"Yuwei Bao's personal website"}],["meta",{"property":"og:title","content":"Clinical trials basics"}],["meta",{"property":"og:type","content":"article"}],["meta",{"property":"og:updated_time","content":"2025-04-03T01:37:27.000Z"}],["meta",{"property":"og:locale","content":"en-US"}],["meta",{"property":"article:tag","content":"Tool"}],["meta",{"property":"article:modified_time","content":"2025-04-03T01:37:27.000Z"}]]},"excerpt":"","headers":[{"level":2,"title":"Four phases in clinical trials","slug":"four-phases-in-clinical-trials","link":"#four-phases-in-clinical-trials","children":[]},{"level":2,"title":"Handling intercurrent events (ICE)","slug":"handling-intercurrent-events-ice","link":"#handling-intercurrent-events-ice","children":[]},{"level":2,"title":"Types of missing data","slug":"types-of-missing-data","link":"#types-of-missing-data","children":[]}],"git":{"createdTime":1743644247000,"updatedTime":1743644247000,"contributors":[{"name":"yuweibao15","email":"ybao2@tulane.edu","commits":1}]},"readingTime":{"minutes":0.75,"words":225},"filePathRelative":"blog/pharma/phases.md","localizedDate":"April 3, 2025"}`);export{e as data};
